Ares Capital Corp
F:9A2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ares Capital Corp
F:9A2
|
US |
|
L
|
Lowe's Companies Inc
F:LWE
|
US |
|
R
|
Relx PLC
XMUN:RDEB
|
UK |
|
F
|
Fortress Biotech Inc
F:CNB
|
US |
|
T
|
Telefonaktiebolaget LM Ericsson
DUS:ERCB
|
SE |
|
Cantaloupe Inc
F:UTE0
|
US |
|
Japfa Comfeed Indonesia Tbk PT
F:1JC1
|
ID |
|
M
|
Melia Hotels International SA
XMUN:MEL
|
ES |
|
I
|
Industrial and Commercial Bank of China Ltd
XBER:ICK
|
CN |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
Henkel AG & Co KGaA
F:HEN3
|
DE |
Wall St Price Targets
9A2 Price Targets Summary
Ares Capital Corp
According to Wall Street analysts, the average 1-year price target for 9A2 is 20.44 EUR with a low forecast of 17.44 EUR and a high forecast of 24.81 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9A2's stock price target?
Price Target
20.44
EUR
According to Wall Street analysts, the average 1-year price target for 9A2 is 20.44 EUR with a low forecast of 17.44 EUR and a high forecast of 24.81 EUR.
What is the Revenue forecast for Ares Capital Corp?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is -3%.
What is the Operating Income forecast for Ares Capital Corp?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is -1%.
What is the Net Income forecast for Ares Capital Corp?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 2%.
